Skip to content

Clinical trials

Phase 2 Acute Coronary Syndrome trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acute Coronary Syndrome Phase: Phase 2 Country / region: Canada Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20061
20071
20081
20093
20112
20151
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Europe B.V.1
Bristol-Myers Squibb1
CSL Limited1
Cerenis Therapeutics, SA1
GlaxoSmithKline1
Janssen Research & Development, LLC1
Molecular Insight Pharmaceuticals, Inc.1
Ottawa Heart Institute Research Corporation1
Population Health Research Institute1
Regado Biosciences, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acute Coronary Syndrome13
Angina, Unstable3
Myocardial Infarction3
Cardiomyopathy, Hypertrophic1
Coronary Artery Disease1
Coronary Disease1
Coronary Restenosis1
Death, Sudden1
Dyslipidemias1
Hypercholesterolemia1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.